Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer
Jaume Forés-Martos, César Boullosa, David Rodrigo Domínguez, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2990-2990
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA
Michele Salemi, Maria P. Mogavero, Giuseppe Lanza, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1930-1930
Open Access | Times Cited: 26
A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson’s Disease
Michele Salemi, Giuseppe Lanza, Maria P. Mogavero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1535-1535
Open Access | Times Cited: 23
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers
Pierre‐Emmanuel Sugier, Elise A. Lucotte, Cloé Domenighetti, et al.
Movement Disorders (2023) Vol. 38, Iss. 4, pp. 604-615
Open Access | Times Cited: 16
Neurotherapeutic Effects of Quercetin and Its Metabolite Compounds on Cognitive Impairment and Parkinson’s Disease: An In Silico Study
Hai Duc Nguyen
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 2, pp. 151-169
Closed Access | Times Cited: 14
Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
Michele Salemi, Giovanna Marchese, Giuseppe Lanza, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 712-712
Open Access | Times Cited: 21
Apoptosis Genes as a Key to Identification of Inverse Comorbidity of Huntington’s Disease and Cancer
E. Yu. Bragina, Д. Е. Гомбоева, Olga Saik, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9385-9385
Open Access | Times Cited: 12
Nuclear Alpha‐Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
Marı́a E. Jiménez-Capdeville, Érika Chi-Ahumada, Francisco García-Ortega, et al.
Neurology Research International (2025) Vol. 2025, Iss. 1
Open Access
Amyotrophic Lateral Sclerosis and Risk of Common Cancer: Mendelian Randomization Interrogation of Causality and Mediation
Xiaoxue Tan, Gaifen Liu, Xiangnan Li, et al.
Phenomics (2025)
Closed Access
Neuroprotective thiazole sulfonamides against 6-OHDA-induced Parkinsonian model: in vitro biological and in silico pharmacokinetic assessments
Waralee Ruankham, Ratchanok Pingaew, Veda Prachayasittikul, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4281-4295
Open Access
Parkinson’s Disease, Parkinsonisms, and Mitochondria: the Role of Nuclear and Mitochondrial DNA
Andrea Legati, Daniele Ghezzi
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 4, pp. 131-147
Closed Access | Times Cited: 9
Associations of ARHGAP26 Polymorphisms with Alzheimer’s Disease and Cardiovascular Disease
Kesheng Wang, Yongke Lu, Deana F. Morrow, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 5, pp. 1085-1097
Closed Access | Times Cited: 11
Multiomics Topic Modeling for Breast Cancer Classification
Filippo Valle, Matteo Osella, Michele Caselle
Cancers (2022) Vol. 14, Iss. 5, pp. 1150-1150
Open Access | Times Cited: 11
Longitudinal study of the inverse relationship between Parkinson’s disease and cancer in Korea
So Young Kim, Hyo Geun Choi, Yoo Hwan Kim, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Alzheimer’s Disease and Different Types of Cancer Likelihood: Unveiling Disparities and Potential Protective Effects in a Korean Cohort Study
Ho Suk Kang, Ji Hee Kim, Hyun Lim, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4615-4615
Open Access | Times Cited: 6
Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach
Dia Advani, Pravir Kumar
Neuropeptides (2022) Vol. 96, pp. 102283-102283
Closed Access | Times Cited: 9
Metabolomic analysis of vascular cognitive impairment due to hepatocellular carcinoma
Dan Zhu, Yamei Zhu, Lin Liu, et al.
Frontiers in Neurology (2023) Vol. 13
Open Access | Times Cited: 5
Denoising autoencoder-based bulk and single-cell RNA-sequencing data analyses reveal a comorbidity relationship between Alzheimer’s disease and lung cancer
Jialin Li, Mingbo Tang, Xinliang Gao, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Monoamine oxidase B inhibits epithelial‐mesenchymal transition and trigger apoptosis via targeting ERK1/2 signaling pathway in head and neck squamous cell carcinoma
Yibo Qi, Weihua Shao, Jing Gao, et al.
Head & Neck (2024) Vol. 46, Iss. 8, pp. 2031-2041
Closed Access | Times Cited: 1
Natural resistance to cancer: A window of hope
Mohammad Masoudi, Parisa Torabi, Robert L. Judson‐Torres, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 7, pp. 1131-1142
Open Access | Times Cited: 2
Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma
Haoxue Zhang, Yuyao Liu, Delin Hu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
A study of gene expression by RNA-seq in patients with prostate cancer and in patients with Parkinson disease: an example of inverse comorbidity
Pietro Pepe, Simona Vatrano, Rossella Cannarella, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 11, pp. 7627-7631
Closed Access | Times Cited: 5
Differential Neuropathology, Genetics, and Transcriptomics in Two Kindred Cases with Alzheimer’s Disease and Lewy Body Dementia
Ilaria Palmieri, Tino Emanuele Poloni, Valentina Medici, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1687-1687
Open Access | Times Cited: 3
Association between dementia, Alzheimer's disease, and liver cancer: A Mendelian randomization analysis
Tianze Li, Jianwei Yi, Xiang Hu, et al.
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 1587-1595
Open Access
Cancer History Is Associated with Slower Speed of Cognitive Decline in Patients with Amnestic Cognitive Impairment
Rolando I. Castillo-Passi, Rodrigo C. Vergara, Nicole K. Rogers, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 4, pp. 1695-1711
Closed Access | Times Cited: 2
The Crosstalk between HepG2 and HMC-III Cells: In Vitro Modulation of Gene Expression with Conditioned Media
Prashant Koshal, Ilenia Matera, Vittorio Abruzzese, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14443-14443
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top